Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

NCT05828212 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica

Interventions

DRUG: CAR-T cells injection

Sponsor

Zhejiang University

Collaborators

[object Object]